• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Cancer Drugs Fund (CDF) - Articles and news items

leukaemiapricedrop

Price drop means leukaemia CDF drug will be routinely available

Industry news / 2 December 2016 / Niamh Louise Marriott, Digital Editor

Ibrutinib had only previously been available through the CDF. Following a reduction in its price for the NHS, it is now recommended in further guidance…

cdf-all-approved

NICE approves three quarters of CDF drugs for routine NHS use

Industry news / 17 November 2016 / Niamh Louise Marriott, Digital Content Producer

More than 75% of treatments in the Cancer Drugs Fund (CDF) which have been reappraised by the National Institute for Health and Care Excellence (NICE) have received positive recommendations for routine use in the NHS. NICE has been reappraising cancer drugs which had not been recommended in previous NICE guidance (11 drug indications in total), […]

epr-alphabetc

C is for Cancer Drugs Fund

Blog / 16 November 2016 / Niamh Louise Marriott, Digital Content Producer

C is for Cancer Drugs Fund – the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest on the Cancer Drugs Fund

cancer-drugs-fund-featured

UPDATE: The Cancer Drugs Fund

Blog, Industry news / 10 November 2016 / Niamh Louise Marriott, Digital Content Producer

This page will be updated as the results from the Cancer Drugs Fund appraisal are announced by The National Institute of Health and Care Excellence (NICE).  Originally introduced in 2011, The Cancer Drugs Fund (CDF) was established by the coalition Government in order to provide a means by which NHS patients in England could get cancer […]

cancer-drugs

NICE draft guidance recommends treatments for breast and lung cancer

Industry news / 10 November 2016 / Niamh Louise Marriott, Digital Content Producer

NICE recommends 2 cancer drugs for routine use on the NHS as part of its programme to appraise treatments that were available on the Cancer Drugs Fund…

breast-cancer-featured-image

Life-extending breast cancer drug approved by NICE

Industry news / 3 November 2016 / Niamh Louise Marriott, Digital Content Producer

NICE has said eribulin, which is also called Halaven and made by Eisai, should be an option for people with locally advanced or metastatic breast cancer…

bristol-myers-sqibb-cdf

NICE says CDF case for nivolumab to treat lung cancer is not clear cut

Industry news / 14 October 2016 / Niamh Louise Marriott, Digital Content Producer

NICE’s appraisal committee concluded that nivolumab was not cost-effective for all patients in the treatment of non small-cell lung cancer…

drugs-food-cancer

NICE recommends first drug for the Cancer Drugs Fund

Industry news / 4 October 2016 / Niamh Louise Marriott, Digital Content Producer

Osimertinib is the first new cancer drug to be introduced into the NHS under a Cancer Drugs Fund managed access agreement…

cancer drugs

Re-evaluating the Cancer Drugs Fund: Out with the old, in with the new

Blog, Z Homepage promo / 31 August 2016 / Niamh Louise Marriott, Digital Content Producer

In April of this year, NICE started to assess the cost and clinical effectiveness of every drug currently in the old cancer drugs fund…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +